- Design
- Systematic review and meta-analysis of observational studies
- Population
- 22 studies of critically ill and acute cardiovascular patients
- Primary outcome
- Mortality
- Effect
- NTIS OR 3.19 (2.10–4.85), I² 67.5%; isolated low T3 OR 2.93 (2.04–4.20), I² 63.8%
A meta-analysis in Endocrine (28 September) pooled 22 studies of critically ill and acute cardiovascular patients to ask how thyroid changes during illness relate to outcome.
Non-thyroidal illness syndrome was associated with higher mortality (OR 3.19, 95% CI 2.10 to 4.85; 15 studies, 5,230 patients), and so was isolated low T3 (OR 2.93, 2.04 to 4.20; 9 studies, 6,282 patients). Neither definition clearly outperformed the other, and heterogeneity was substantial for both.
The practical message is interpretive. Abnormal thyroid tests in an acutely unwell inpatient usually reflect the severity of illness, not primary thyroid disease, and a low T3 is a marker of risk rather than a deficiency to replace. Checking thyroid function during acute illness often generates results that are hard to act on; if a test was sent and is abnormal, repeat it after recovery before labelling the patient.
- Avoid routine thyroid function tests in acutely unwell inpatients unless thyroid disease is suspected.
- Read a low T3 or low-normal TSH in acute illness as a severity marker, not hypothyroidism.
- Repeat abnormal thyroid tests several weeks after recovery before diagnosing or treating.
- Record abnormal results clearly so they are not acted on out of context after discharge.
Why it matters
It reframes an abnormal inpatient thyroid panel as prognostic information, not a new diagnosis.
Don't overread it
This does not suggest thyroid hormone replacement improves survival in acute illness.
The statistics, in plain English
An odds ratio of about 3 means patients with these thyroid changes had roughly three times the odds of dying. That is an association: sicker patients have both lower T3 and higher mortality, so it says nothing about whether treating the T3 would help. I² above 60% means the studies disagreed on the size of the effect.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for internal medicine, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free